DaVita HealthCare Partners Inc.

DaVita HealthCare Partners Inc.

DaVita is a healthcare company which provides kidney dialysis and related services to patients with chronic kidney failure.

Stock Performance Snapshot

Hold

Analyst Rating

Analysts suggest holding DaVita's stock with a target price of $139.88, indicating limited growth potential.

Above Average

Financial Health

DaVita is performing well, showing strong revenue, cash flow, and profitability metrics.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring DVA

Walgreens Restructuring Explained: Investment Shifts

Walgreens Restructuring Explained: Investment Shifts

Following its acquisition by Sycamore Partners, Walgreens has gone private and split into five companies. This theme explores the investment opportunities created by the newly independent healthcare and retail entities.

Published: September 2, 2025

Explore Basket
Following Buffett's Healthcare Bet

Following Buffett's Healthcare Bet

Warren Buffett's Berkshire Hathaway is making a major $2.1 billion bet on UnitedHealth, signaling a strategic shift toward the healthcare sector. This theme focuses on other health insurers and healthcare providers that could benefit from this renewed investor confidence.

Published: August 15, 2025

Explore Basket
Bye-Bye Buffet: The 5,500,000% Investor

Bye-Bye Buffet: The 5,500,000% Investor

Follow in the footsteps of Warren Buffett, one of history's greatest investors, with this carefully selected portfolio of his favorite companies. As Buffett prepares to step down as Berkshire's CEO, now's your chance to invest like the Oracle of Omaha.

Published: May 18, 2025

Explore Basket
Pharma

Pharma

Health is wealth, and these carefully selected pharmaceutical companies could help your portfolio grow. Our professional analysts have handpicked these stocks from an industry that's projected to reach $1.9 trillion by 2027.

Published: May 6, 2025

Explore Basket

Why Youโ€™ll Want to Watch This Stock

๐Ÿ“ˆ

Patient Demand Trends

Ageing populations and rising chronic kidney disease rates support long-term demand, though patient volumes and reimbursement can fluctuate.

๐ŸŒ

Payer Mix Impact

Revenue and margins depend heavily on Medicare/Medicaid versus commercial contracts; regulatory or payment changes can materially affect results.

โšก

Operational Efficiency Levers

Margins hinge on site utilisation, staffing and cost control; efficiency gains may help profitability but execution risk remains.

Why invest with Nemo?

Nemo Logo Fade
๐Ÿ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

๐Ÿ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

๐Ÿ’ฐ

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

UNH

UnitedHealth Group Incorporated

Provides healthcare services to individuals and organizations

CVS

CVS Health Corporation

CVS Health is a healthcare company that provides pharmacy, health insurance, and other healthcare services.

HCA

HCA Holdings, Inc.

A healthcare services company dedicated to providing high quality, cost effective care.

Frequently asked questions